Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Uxin (UXIN) EBITDA (2018 - 2025)

Historic EBITDA for Uxin (UXIN) over the last 8 years, with Q3 2025 value amounting to -$54.2 billion.

  • Uxin's EBITDA rose 1773.65% to -$54.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$54.3 billion, marking a year-over-year increase of 9999.98%. This contributed to the annual value of -$46.5 million for FY2024, which is N/A changed from last year.
  • Uxin's EBITDA amounted to -$54.2 billion in Q3 2025, which was up 1773.65% from -$9.4 million recorded in Q2 2025.
  • In the past 5 years, Uxin's EBITDA registered a high of $1330.8 billion during Q4 2021, and its lowest value of -$23900000.0 billion during Q2 2024.
  • Over the past 5 years, Uxin's median EBITDA value was -$10.9 million (recorded in 2024), while the average stood at -$1257863.7 billion.
  • In the last 5 years, Uxin's EBITDA skyrocketed by 124337.04% in 2021 and then tumbled by 19628777913784.49% in 2024.
  • Uxin's EBITDA (Quarter) stood at $1330.8 billion in 2021, then crashed by 100.0% to -$90986.0 in 2022, then rose by 15.52% to -$76863.0 in 2023, then plummeted by 14111.0% to -$10.9 million in 2024, then tumbled by 496448.57% to -$54.2 billion in 2025.
  • Its EBITDA was -$54.2 billion in Q3 2025, compared to -$9.4 million in Q2 2025 and -$7.1 million in Q1 2025.